文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

巴基斯坦冲突地区社区参与及综合卫生与脊灰免疫接种活动的整群随机对照试验

Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.
PubMed 文献 · Lancet Glob Health · 2017-01-01

在巴基斯坦3个脊灰高风险地区开展三臂整群随机试验,比较常规脊灰规划活动(A组)、加社区动员与妇幼保健营的综合干预(B组)、B组方案加IPV(C组)。结果显示C组OPV覆盖率84%、B组82%,均高于A组75%;常规疫苗剂次比例亦提高,未报告需住院的严重不良事件。

要点

  • 社区动员与妇幼保健营可提高脊灰及常规免疫覆盖
  • C组OPV覆盖率84%,B组82%,A组75%
  • 未报告免疫后需住院的严重不良事件

核心结论

  • 在高风险、受冲突影响的巴基斯坦地区,脊灰免疫活动期间开展社区动员及有针对性的社区妇幼保健与免疫接种营,成功提高了疫苗覆盖率,包括脊灰疫苗覆盖率。

研究设计与样本

  • 研究为基于社区的三臂整群随机试验,对象为研究地点内1月龄至5岁健康儿童;由外部统计员用计算机算法按20个为一组进行限制性随机化(1:1:1)分配集群。
  • A组接受常规脊灰规划活动;B组增加社区外展与动员(强化沟通包)及短期预防性妇幼保健服务和常规免疫(保健营),包括OPV;C组在B组全部干预基础上,于妇幼保健营提供IPV。
  • 独立团队在基线、终线及每轮补充免疫活动后开展调查,评估可接受性与效果;试验注册号ClinicalTrials.gov NCT01908114。

主要发现

  • 2013年6月4日至2014年5月31日共随机化387个集群(A组131、B组127、C组129);基线记录5岁以下儿童A组28760名、B组30098名、C组29126名。
  • 至试验结束剩359个集群(A组116、B组120、C组123),5岁以下儿童A组23334名、B组26110名、C组25745名。
  • 估计OPV覆盖率A组75%,B组82%(与A组差异6.6%,95%CI 4.8-8.3),C组84%(差异8.5%,95%CI 6.8-10.1;总体p<0.0001)。
  • 24月龄以下儿童平均常规疫苗剂次比例A组43%、B组52%(差异9%,95%CI 7-11)、C组54%(差异11%,95%CI 9-13;总体p<0.0001)。
  • 免疫后未报告需住院的严重不良事件。

临床怎么用

  • 作者认为,在巴基斯坦高风险、受冲突影响地区的脊灰终局阶段,脊灰免疫活动期间开展社区动员及有针对性的社区妇幼保健与免疫接种营的策略成功提高了疫苗覆盖率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pakistan faces huge challenges in eradicating polio due to widespread poliovirus transmission and security challenges. Innovative interventions are urgently needed to strengthen community buy-in, to increase the coverage of oral polio vaccine (OPV) and other routine immunisations, and to enhance immunity through the introduction of inactivated polio vaccine (IPV) in combination with OPV. We aimed to evaluate the acceptability and effect on immunisation coverage of an integrated strategy for community engagement and maternal and child health immunisation campaigns in insecure and conflict-affected polio-endemic districts of Pakistan. METHODS: We did a community-based three-arm cluster randomised trial in healthy children aged 1 month to 5 years that resided within the study sites in three districts of Pakistan at high risk of polio. Clusters were randomly assigned by a computer algorithm using restricted randomisation in blocks of 20 by an external statistician (1:1:1) to receive routine polio programme activities (control, arm A), additional interventions with community outreach and mobilisation using an enhanced communication package and provision of short-term preventive maternal and child health services and routine immunisation (health camps), including OPV (arm B), or all interventions of arm B with additional provision of IPV delivered at the maternal and child health camps (arm C). An independent team conducted surveys at baseline, endline, and after each round of supplementary immunisation activity for acceptability and effect. The primary outcome measures for the study were coverage of OPV, IPV, and routine extended programme on immunisation vaccines and changes in the proportion of unvaccinated and fully vaccinated children. This trial is registered with ClinicalTrials.gov, number NCT01908114. FINDINGS: Between June 4, 2013, and May 31, 2014, 387 clusters were randomised (131 to arm A, 127 to arm B, and 129 to arm C). At baseline, 28 760 children younger than 5 years were recorded in arm A, 30 098 in arm B, and 29 126 in arm C. 359 clusters remained in the trial until the end (116 in arm A, 120 in arm B, and 123 in arm C; with 23 334 children younger than 5 years in arm A, 26 110 in arm B, and 25 745 in arm C). The estimated OPV coverage was 75% in arm A compared with 82% in arm B (difference vs arm A 6·6%; 95% CI 4·8-8·3) and 84% in arm C (8·5%, 6·8-10·1; overall p<0·0001). The mean proportion of routine vaccine doses received by children younger than 24 months of age was 43% in arm A, 52% in arm B (9%, 7-11) and 54% in arm C (11%, 9-13; overall p<0·0001). No serious adverse events requiring hospitalisation were reported after immunisation. INTERPRETATION: Despite the challenges associated with the polio end-game in high-risk, conflict-affected areas of Pakistan, a strategy of community mobilisation and targeted community-based health and immunisation camps during polio immunisation campaigns was successful in increasing vaccine coverage, including polio vaccine coverage. FUNDING: Bill & Melinda Gates Foundation.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Habib MA, Soofi S, Cousens S, et al. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial. Lancet Glob Health. 2017. PMID: 28495264. doi:10.1016/S2214-109X(17)30184-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。